Clinical Investigation to Evaluate the Ability of MammoWave in Breast Lesions Detection (DE-17-17)
A Multicentric, Single Arm, Prospective, Stratified Clinical Investigation to Evaluate the Ability of MammoWave in Breast Lesions Detection
Sponsor: Umbria Bioengineering Technologies
Listed as NCT04253366, this NA trial focuses on Breast Cancer and remains completed. Sponsored by Umbria Bioengineering Technologies, it has been updated 9 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
▶ Show 4 earlier versions
-
Oct 2020 — Nov 2020 [monthly]
Active Not Recruiting NA
Status: Not Yet Recruiting → Active Not Recruiting
-
Aug 2020 — Oct 2020 [monthly]
Not Yet Recruiting NA
-
Apr 2020 — Aug 2020 [monthly]
Not Yet Recruiting NA
-
Mar 2020 — Apr 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Umbria Bioengineering Technologies
For direct contact, visit the study record on ClinicalTrials.gov .